
Minh D. Truong
Examiner (ID: 12235, Phone: (571)270-3014 , Office: P/3654 )
| Most Active Art Unit | 3654 |
| Art Unit(s) | 3654, 3619, 4187 |
| Total Applications | 866 |
| Issued Applications | 545 |
| Pending Applications | 76 |
| Abandoned Applications | 265 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 84097
[patent_doc_number] => 07741460
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-22
[patent_title] => 'Polynucleotides encoding a truncated ORF2 from Corynebacterium'
[patent_app_type] => utility
[patent_app_number] => 10/771695
[patent_app_country] => US
[patent_app_date] => 2004-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 20866
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/741/07741460.pdf
[firstpage_image] =>[orig_patent_app_number] => 10771695
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/771695 | Polynucleotides encoding a truncated ORF2 from Corynebacterium | Feb 3, 2004 | Issued |
Array
(
[id] => 7083193
[patent_doc_number] => 20050048573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'PDE5A crystal structure and uses'
[patent_app_type] => utility
[patent_app_number] => 10/771833
[patent_app_country] => US
[patent_app_date] => 2004-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 81502
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048573.pdf
[firstpage_image] =>[orig_patent_app_number] => 10771833
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/771833 | PDE5A crystal structure and uses | Feb 2, 2004 | Abandoned |
Array
(
[id] => 7672951
[patent_doc_number] => 20040180828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Caspase-9 : BIR domain of XIAP complexes and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/769218
[patent_app_country] => US
[patent_app_date] => 2004-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11508
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180828.pdf
[firstpage_image] =>[orig_patent_app_number] => 10769218
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/769218 | Caspase-9 : BIR domain of XIAP complexes and methods of use | Jan 29, 2004 | Abandoned |
Array
(
[id] => 5693775
[patent_doc_number] => 20060153922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Light induced immobilisation'
[patent_app_type] => utility
[patent_app_number] => 10/542159
[patent_app_country] => US
[patent_app_date] => 2004-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 14055
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20060153922.pdf
[firstpage_image] =>[orig_patent_app_number] => 10542159
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/542159 | Light induced immobilisation | Jan 21, 2004 | Abandoned |
Array
(
[id] => 7089050
[patent_doc_number] => 20050009163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Methods of using crystal structure of carboxyltransferase domain of acetyl-CoA carboxylase, modulators thereof, and computer methods'
[patent_app_type] => utility
[patent_app_number] => 10/754687
[patent_app_country] => US
[patent_app_date] => 2004-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 39124
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20050009163.pdf
[firstpage_image] =>[orig_patent_app_number] => 10754687
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/754687 | Carboxyltransferase domain of acetyl-CoA carboxylase | Jan 8, 2004 | Issued |
Array
(
[id] => 7432287
[patent_doc_number] => 20040209804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Human growth hormone crystals and methods for preparing them'
[patent_app_type] => new
[patent_app_number] => 10/749962
[patent_app_country] => US
[patent_app_date] => 2003-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 25083
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209804.pdf
[firstpage_image] =>[orig_patent_app_number] => 10749962
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/749962 | Human growth hormone crystals and methods for preparing them | Dec 30, 2003 | Issued |
| 10/110330 | Tailored peptide synthetases, a method for their production and the use thereof | Dec 22, 2003 | Abandoned |
Array
(
[id] => 7034180
[patent_doc_number] => 20050032690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Factor VII polypeptides for preventing formation of inhibitors in subjects with haemophilia'
[patent_app_type] => utility
[patent_app_number] => 10/737936
[patent_app_country] => US
[patent_app_date] => 2003-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9670
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032690.pdf
[firstpage_image] =>[orig_patent_app_number] => 10737936
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/737936 | Factor VII polypeptides for preventing formation of inhibitors in subjects with haemophilia | Dec 16, 2003 | Abandoned |
Array
(
[id] => 7097801
[patent_doc_number] => 20050130260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Refolded membrane protein in monodisperse form'
[patent_app_type] => utility
[patent_app_number] => 10/736448
[patent_app_country] => US
[patent_app_date] => 2003-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6581
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130260.pdf
[firstpage_image] =>[orig_patent_app_number] => 10736448
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/736448 | Refolded membrane protein in monodisperse form | Dec 14, 2003 | Abandoned |
Array
(
[id] => 7406004
[patent_doc_number] => 20040175817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Crystallised catalytic domain of matrix metalloproteinase 9 (mmp9) and the use of its three dimensional structure to design mmp9 modulators'
[patent_app_type] => new
[patent_app_number] => 10/480621
[patent_app_country] => US
[patent_app_date] => 2003-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 105784
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20040175817.pdf
[firstpage_image] =>[orig_patent_app_number] => 10480621
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/480621 | Crystallised catalytic domain of matrix metalloproteinase 9 (mmp9) and the use of its three dimensional structure to design mmp9 modulators | Dec 11, 2003 | Abandoned |
Array
(
[id] => 5776792
[patent_doc_number] => 20060105432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Method for the production of vitamin b12'
[patent_app_type] => utility
[patent_app_number] => 10/541920
[patent_app_country] => US
[patent_app_date] => 2003-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14031
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20060105432.pdf
[firstpage_image] =>[orig_patent_app_number] => 10541920
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/541920 | Method for the production of vitamin b12 | Dec 11, 2003 | Abandoned |
Array
(
[id] => 4932873
[patent_doc_number] => 20080003648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'Method to prepare macrolide analogs'
[patent_app_type] => utility
[patent_app_number] => 10/733184
[patent_app_country] => US
[patent_app_date] => 2003-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8528
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20080003648.pdf
[firstpage_image] =>[orig_patent_app_number] => 10733184
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/733184 | Method to prepare macrolide analogs | Dec 9, 2003 | Abandoned |
Array
(
[id] => 7338090
[patent_doc_number] => 20040132967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Respiratory distress syndrome therapy with peptide analogs of human SP-B'
[patent_app_type] => new
[patent_app_number] => 10/730964
[patent_app_country] => US
[patent_app_date] => 2003-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6859
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20040132967.pdf
[firstpage_image] =>[orig_patent_app_number] => 10730964
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/730964 | Respiratory distress syndrome therapy with peptide analogs of human SP-B | Dec 7, 2003 | Abandoned |
Array
(
[id] => 7428290
[patent_doc_number] => 20040209322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold'
[patent_app_type] => new
[patent_app_number] => 10/727696
[patent_app_country] => US
[patent_app_date] => 2003-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8589
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209322.pdf
[firstpage_image] =>[orig_patent_app_number] => 10727696
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/727696 | Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold | Dec 2, 2003 | Abandoned |
Array
(
[id] => 7166514
[patent_doc_number] => 20040077016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Mutant kanamycin nucleotidyltransferase and a method of screening thermophilic bacteria using the same'
[patent_app_type] => new
[patent_app_number] => 10/718628
[patent_app_country] => US
[patent_app_date] => 2003-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5028
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077016.pdf
[firstpage_image] =>[orig_patent_app_number] => 10718628
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/718628 | Mutant kanamycin nucleotidyltransferase and a method of screening thermophilic bacteria using the same | Nov 23, 2003 | Abandoned |
Array
(
[id] => 7471381
[patent_doc_number] => 20040096951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Crystal structures of retaining glycosytransferases'
[patent_app_type] => new
[patent_app_number] => 10/450802
[patent_app_country] => US
[patent_app_date] => 2003-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 157889
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 32
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20040096951.pdf
[firstpage_image] =>[orig_patent_app_number] => 10450802
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/450802 | Crystal structures of retaining glycosytransferases | Nov 16, 2003 | Abandoned |
Array
(
[id] => 188178
[patent_doc_number] => 07647217
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-12
[patent_title] => 'Structure of the farnesoid X receptor ligand binding domain and methods of use therefor'
[patent_app_type] => utility
[patent_app_number] => 10/535042
[patent_app_country] => US
[patent_app_date] => 2003-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 66050
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/647/07647217.pdf
[firstpage_image] =>[orig_patent_app_number] => 10535042
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/535042 | Structure of the farnesoid X receptor ligand binding domain and methods of use therefor | Nov 13, 2003 | Issued |
Array
(
[id] => 7466366
[patent_doc_number] => 20040101936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Process for producing avermectin derivative'
[patent_app_type] => new
[patent_app_number] => 10/204862
[patent_app_country] => US
[patent_app_date] => 2003-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14073
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20040101936.pdf
[firstpage_image] =>[orig_patent_app_number] => 10204862
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/204862 | Process for producing avermectin derivative | Oct 28, 2003 | Abandoned |
Array
(
[id] => 5148669
[patent_doc_number] => 20070048728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Hydroxylases and modulators thereof'
[patent_app_type] => utility
[patent_app_number] => 10/531662
[patent_app_country] => US
[patent_app_date] => 2003-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14432
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048728.pdf
[firstpage_image] =>[orig_patent_app_number] => 10531662
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/531662 | Method of identifying a chemical entity which is a hydroxylase modulator | Oct 15, 2003 | Issued |
Array
(
[id] => 5851102
[patent_doc_number] => 20060234293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Polypeptide methods and means'
[patent_app_type] => utility
[patent_app_number] => 10/531242
[patent_app_country] => US
[patent_app_date] => 2003-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 15578
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234293.pdf
[firstpage_image] =>[orig_patent_app_number] => 10531242
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/531242 | Polypeptide methods and means | Oct 13, 2003 | Abandoned |